Master Study of the Implantable Cardiac Monitor "BioMonitor"
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Biotronik SE & Co. KG
- Enrollment
- 152
- Locations
- 1
- Primary Endpoint
- SADE free-rate
Study Overview
Brief Summary
The BioMonitor is an implantable cardiac monitor used to automatically detect and record episodes of arrhythmia in patients with bradycardia, tachycardia, asystole and atrial fibrillation. The study will be conducted to support regulatory approvals outside of Europe. This BioMonitor Master study is designed to investigate the clinical efficacy and safety of the BioMonitor.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Suspected cardiac arrhythmia OR Previous AF diagnosis OR AF diagnosis before or after ablation procedure OR Stroke of unknown origin.
Exclusion Criteria
- •Implanted ICD or cardiac pacemaker
- •Allergy to patch electrodes
Outcomes
Primary Outcomes
SADE free-rate
Time Frame: at 3 month follow-up
SADE free-rate \> 90% at 3 month follow-up
Rate of appropriate QRS detection
Time Frame: at 6 week follow-up
Rate of appropriate QRS detection \> 90% (based on comparison with Holter ECG recording)
Secondary Outcomes
No secondary outcomes reported
